Mon, April 25, 2011
[ Mon, Apr 25th 2011 ]: Market Wire
Somaxon Pharmaceuticals to Report First Quarter 2 .. lts and Conduct Conference Call on Tuesday, May 3
[ Mon, Apr 25th 2011 ]: Market Wire
Health Management 1st Quarter 2011 Diluted EPS fr .. reases 16% to $0.22 and Net Revenue Increases 13%
[ Mon, Apr 25th 2011 ]: Market Wire
Aetna Announces Appearance at the Deutsche Bank 26th Annual Health Care Conference
[ Mon, Apr 25th 2011 ]: Market Wire
Pro-Pharmaceuticals Expands Patent Coverage to Japan
[ Mon, Apr 25th 2011 ]: Market Wire
Vandetanib Now Available to U.S. Patients with Advanced Medullary Thyroid Cancer
[ Mon, Apr 25th 2011 ]: Market Wire
AstraZeneca and POZEN File Patent Infringement Lawsuit Against Dr. Reddya?s
[ Mon, Apr 25th 2011 ]: Market Wire
Cambridge Heart Announces New Software Release
[ Mon, Apr 25th 2011 ]: Market Wire
Amerinet Signs New Agreement with Teleflex Incorp .. for Arrow Peripherally Inserted Central Catheters
[ Mon, Apr 25th 2011 ]: Market Wire
Salix Pharmaceuticals to Present at Two Investment Conferences in May
[ Mon, Apr 25th 2011 ]: Market Wire
XenoPort Announces FDA Agreement on a Special Pro .. al Phase 3 Clinical Trial of Arbaclofen Placarbil
Fri, April 22, 2011
[ Fri, Apr 22nd 2011 ]: Market Wire
Sanofi Pasteur Announces FDA Approval of Menactra .. gococcal Conjugate Vaccine Indication for Infants
[ Fri, Apr 22nd 2011 ]: Market Wire
Community Health Systems Responds to Tenet Rejection of All-Cash Offer
[ Fri, Apr 22nd 2011 ]: Market Wire
Humana Military Sponsors Fleet Week Port Everglades 2011
[ Fri, Apr 22nd 2011 ]: Market Wire
Tenet Healthcare Board of Directors Unanimously R .. nsolicited Proposal from Community Health Systems
[ Fri, Apr 22nd 2011 ]: Market Wire
UnitedHealthcare, New England Revolution Announce Partnership
[ Fri, Apr 22nd 2011 ]: Market Wire
30 p.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2011
[ Fri, Apr 22nd 2011 ]: Market Wire
Idera Pharmaceuticals Delays Initiation of Phase .. Trial of IMO-2125 in Treatment-Nave HCV Patients
[ Fri, Apr 22nd 2011 ]: Market Wire
BioCryst to Present New BCX4208 Gout Results at the Annual European Congress of Rheumatology
[ Fri, Apr 22nd 2011 ]: Market Wire
Inspire Postpones Annual Meeting of Stockholders Due to Recently Announced Tender Offer
[ Fri, Apr 22nd 2011 ]: Market Wire
PLC Systems' Chief Financial Officer to Leave Company to Become CEO of Clinquest
Thu, April 21, 2011
[ Thu, Apr 21st 2011 ]: Market Wire
Curis to Release First Quarter 2011 Financial Results and Hold Conference Call on April 28, 2011
[ Thu, Apr 21st 2011 ]: Market Wire
Thermo Fisher Scientific to Present at the 36th A .. utsche Bank Health Care Conference on May 4, 2011
[ Thu, Apr 21st 2011 ]: Market Wire
Five Star Quality Care, Inc. First Quarter Conference Call Scheduled for Thursday, April 28th
[ Thu, Apr 21st 2011 ]: Market Wire
Merck and Sanofi Pasteur Initiate Phase III Study .. atric Combination Vaccine to Help Prevent Six Inf
[ Thu, Apr 21st 2011 ]: Market Wire
POZEN Announces May 5, 2011 Webcast of First Quarter 2011 Results
[ Thu, Apr 21st 2011 ]: Market Wire
Repligen Reports Preliminary Fiscal Year 2011 Fin .. Guidance and Development Goals for Fiscal Year 20
[ Thu, Apr 21st 2011 ]: Market Wire
Alexion Reports First Quarter 2011 Results
[ Thu, Apr 21st 2011 ]: Market Wire
Biogen Idec Reports First Quarter 2011 Results
[ Thu, Apr 21st 2011 ]: Market Wire
Covidien annuncia i risultati del secondo trimestre
[ Thu, Apr 21st 2011 ]: Market Wire
ICON Reports First Quarter 2011 Revenue up 5% to $229 Million and EPS of 21c
Wed, April 20, 2011
[ Wed, Apr 20th 2011 ]: Market Wire
CytRx Increases Clinical Sites to 15 in Tamibarot .. n 1st Line Non-Small-Cell Lung Cancer to Expedite
[ Wed, Apr 20th 2011 ]: Market Wire
Ligand Partner Prism Pharmaceuticals to be Acquired by Baxter
[ Wed, Apr 20th 2011 ]: Market Wire
RTI Biologics Schedules 2011 First Quarter Earnings and Conference Call for April 28, 2011
[ Wed, Apr 20th 2011 ]: Market Wire
Rochea?s RTCA HT Instrument Adapts Real-Time Cell Analysis to a High-Throughput Format
[ Wed, Apr 20th 2011 ]: Market Wire
Oncolytics Biotech® Inc. Announces Positive .. cal Trial Investigating REOLYSIN® in Patient
[ Wed, Apr 20th 2011 ]: Market Wire
Acorda Therapeutics Announces Changes to Board of Directors
[ Wed, Apr 20th 2011 ]: Market Wire
The Ludwig Institute and Pro-Pharmaceuticals Disc .. he Ability of Anti-Tumor T Lymphocytes to Kill Tu
[ Wed, Apr 20th 2011 ]: Market Wire
Salix Pharmaceuticals Secures Additional Intellectual Property Relating to Rifaximin
[ Wed, Apr 20th 2011 ]: Market Wire
AngioDynamics to Present at Upcoming Investor Conferences in May 2011
Tue, April 19, 2011
[ Tue, Apr 19th 2011 ]: Market Wire
Furiex Acquires Full Exclusive License Rights to .. evelop and Commercialize JNJ-Q2 (fluoroquinolone)
[ Tue, Apr 19th 2011 ]: Market Wire
Edwards Lifesciences' Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan
[ Tue, Apr 19th 2011 ]: Market Wire
Aoxing Pharmaceutical Company Completes Technolog .. ansfer in Joint Venture With Macfarlan Smith Ltd.
[ Tue, Apr 19th 2011 ]: Market Wire
Medtronic Introduces the MARROWMAXa" Bone Marrow Aspiration Needle Kit
[ Tue, Apr 19th 2011 ]: Market Wire
MannKind Corporation to Hold 2011 First Quarter Financial Results Conference Call on May 9, 2011
[ Tue, Apr 19th 2011 ]: Market Wire
Biomagnetics Begins Receiving Funding From BIOTECH Development Partners
[ Tue, Apr 19th 2011 ]: Market Wire
Forest Laboratories and Blue Ash Therapeutics Ent .. ent for Azimilide, a Novel Phase III Antiarrhythm
[ Tue, Apr 19th 2011 ]: Market Wire
Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2011 Earnings Per Share of $1.12
[ Tue, Apr 19th 2011 ]: Market Wire
Precision NanoSystems and Alnylam Form New Delivery Collaboration

Covidien annuncia i risultati del secondo trimestre

DUBLINO--([ BUSINESS WIRE ])--Covidien plc (NYSE: COV) oggi ha annunciato i risultati per il secondo trimestre della™anno fiscale 2011 (gennaio - marzo 2011). Il fatturato netto, pari a 2,80 miliardi di dollari, aumentato del 10% rispetto al fatturato di $2,55 mld annunciato il secondo trimestre della™anno scorso. Le oscillazioni valutarie hanno aggiunto circa due punti percentuali al tasso di crescita del fatturato trimestrale.

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.